Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Enphase Energy | ENPH | 17. avr 2025 | 52.54 | +1.53 |
Enpro | NPO | 17. avr 2025 | 144.28 | +0.45 |
Enservco | ENSV | 17. avr 2025 | 0.03 | +10.00 |
Enstar Group | ESGR | 17. avr 2025 | 334.01 | +0.31 |
Enstar Group Depository E Pref | ESGRO | 17. avr 2025 | 19.67 | -0.15 |
Enstar Pref | ESGRP | 17. avr 2025 | 19.64 | -2.24 |
Ensysce Biosciences | ENSC | 17. avr 2025 | 1.76 | -6.38 |
Entegris | ENTG | 17. avr 2025 | 68.73 | +1.67 |
Entera Bio | ENTX | 17. avr 2025 | 1.79 | +1.70 |
Entergy | ETR | 17. avr 2025 | 83.27 | +1.25 |
Entergy Texas A Pref | ETI- | 17. avr 2025 | 23.32 | -0.67 |
Entergy Utility Enterprises | EMP | 17. avr 2025 | 20.25 | -0.05 |
Entero Therapeutics | ENTO | 17. avr 2025 | 0.38 | -0.73 |
Enterprise Bancorp | EBTC | 17. avr 2025 | 35.03 | +0.43 |
Enterprise Financial Services | EFSC | 17. avr 2025 | 48.60 | +1.14 |
Enterprise Financial Services A Pref | EFSCP | 17. avr 2025 | 17.67 | +0.98 |
Enterprise Products Partners LP Unit | EPD | 17. avr 2025 | 31.02 | +1.91 |
Entrada Therapeutics | TRDA | 17. avr 2025 | 8.13 | +3.44 |
Entravision Communications | EVC | 17. avr 2025 | 1.88 | 0.00 |
Envela | ELA | 17. avr 2025 | 6.12 | +1.83 |
Enveric Biosciences | ENVB | 17. avr 2025 | 1.17 | -4.88 |
Enviri | NVRI | 17. avr 2025 | 5.86 | +2.81 |
Environmental Svcs ETF Market Vectors | EVX | 17. avr 2025 | 34.46 | +0.47 |
Envirotech Vehicles | EVTV | 17. avr 2025 | 0.24 | -0.33 |
Envista | NVST | 17. avr 2025 | 15.18 | +1.07 |
Envoy Medical A | COCH | 17. avr 2025 | 1.34 | +1.52 |
enVVeno Medical | NVNO | 17. avr 2025 | 2.45 | +2.94 |
Enzo Biochem | ENZ | 17. avr 2025 | 0.31 | -17.77 |
EOG Resources | EOG | 17. avr 2025 | 110.50 | +2.09 |
EON Resources A | EONR | 17. avr 2025 | 0.47 | -1.45 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.